Mead Johnson Board of Directors Declares Dividend
The dividend will be paid on
About Mead Johnson
Mead Johnson, a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in over 50 markets worldwide. The company’s mission is to nourish the world’s children for the best start in life. The Mead Johnson name has been associated with science-based pediatric nutrition products for over 100 years. The company’s “Enfa” family of brands, including Enfamil® infant formula, is the world’s leading brand franchise in pediatric nutrition. For more information, visit meadjohnson.com.
Forward-Looking Statements
Certain statements in this news release are forward-looking as
defined in the Private Securities Litigation Reform Act of 1995. These
forward-looking statements may be identified by the fact they use words
such as “should,” “expect,” “anticipate,” “estimate,” “target,” “may,”
“project,” “guidance,” “intend,” “plan,” “believe” and other words and
terms of similar meaning and expression. Such statements are
likely to relate to, among other things, a discussion of goals, plans
and projections regarding financial position, results of operations,
cash flows, market position, product development, product approvals,
sales efforts, expenses, capital expenditures, performance or results of
current and anticipated products and the outcome of contingencies such
as legal proceedings and financial results. Forward-looking
statements can also be identified by the fact that they do not relate
strictly to historical or current facts. Such forward-looking statements
are based on current expectations that involve inherent risks,
uncertainties and assumptions that may cause actual results to differ
materially from expectations as of the date of this news release. These
risks include, but are not limited to: (1) the ability to sustain brand
strength, particularly the Enfa family of brands; (2) the effect on the
company's reputation of real or perceived quality issues; (3) the effect
of regulatory restrictions related to the company’s products; (4) the
adverse effect of commodity costs; (5) increased competition from
branded, private label, store and economy-branded products; (6) the
effect of an economic downturn on consumers' purchasing behavior and
customers' ability to pay for product; (7) inventory reductions by
customers; (8) the adverse effect of changes in foreign currency
exchange rates; (9) the effect of changes in economic, political and
social conditions in the markets where we operate; (10) changing
consumer preferences; (11) the possibility of changes in the Women,
Infant and Children (WIC) program, or participation in WIC; (12)
legislative, regulatory or judicial action that may adversely affect the
company's ability to advertise its products or maintain product margins;
and (13) the ability to develop and market new, innovative products. For
additional information regarding these and other factors, see the
company’s filings with the
Source:
Mead Johnson Nutrition Company
Investors:
Kathy
MacDonald, (847) 832-2182
kathy.macdonald@mjn.com
or
Media:
Christopher
Perille, (847) 832-2178
chris.perille@mjn.com
6/13/2013